JBS (JBS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
10 Sep, 2026Executive summary
Net sales reached a record $24 billion in Q2 2026, up 14% year-over-year, with adjusted EBITDA at $1.43 billion (6% margin), but profitability declined due to high input costs and non-recurring items, resulting in a net loss of $102 million and adjusted net income of $218 million.
Leadership transition announced: Wesley Batista Filho to become CEO in January 2027, ensuring continuity in strategy and priorities.
The business remains focused on operational excellence, disciplined capital allocation, and long-term value creation across a diversified global platform.
Segment results were mixed, with strong growth in Australia and Brazil offset by losses in North America beef.
Adjusted EBITDA margin declined from 8.4% to 6.0% year-over-year.
Financial highlights
Net sales/revenue for Q2 2026 reached $24 billion, up from $21.0 billion in Q2 2025.
Adjusted EBITDA was $1.43 billion (6% margin, IFRS), down from $1.75 billion (8.4% margin) in Q2 2025.
Adjusted operating income was $790 million (3.3% margin, IFRS); net loss was $102 million, with negative EPS of $0.10, impacted by $319 million in higher net financial expenses and other non-recurring items.
Excluding non-recurring items, adjusted net income was $218 million and EPS was $0.20.
Free cash flow improved to $130 million, up $185 million year-over-year.
Outlook and guidance
Priorities for the second half include execution, cash generation, and reducing leverage.
Working capital consumption for 2026 is expected to improve by $500 million versus last year.
CapEx for 2026 is forecast at $2 billion, $400 million lower than initial estimates.
Net leverage ended Q2 at 3.1x, above the long-term target of 2x–3x, with expectations to finish the year at similar levels.
Management expects continued volatility in commodity and energy markets due to geopolitical tensions and inflationary pressures.
Latest events from JBS
- Global protein leader with $91.2B revenue, rising margins, and strong global diversification.JBS
Institutional presentation - Sustainable growth, margin expansion, and global diversification drive strong returns.JBS
Investor Day 2026 presentation - Global protein leader with $88.3B revenue, margin growth, and expanding global footprint.JBS
Investor presentation - Global protein leader with $88.3B revenue, expanding through diversification and strategic investment.JBS
Investor presentation - Net sales up 11% to $21.6B–$22B, but EBITDA and net income declined; leverage at 2.77x.JBS
Q1 2026 - Record $86.2B revenue and $2.02B net income in 2025, with margin pressure in North America.JBS
Q4 2025 - Record 3Q24: $19.9B revenue, $2.2B EBITDA, $693M profit, leverage at 2.15x.JBS
Q3 2024 - Q2 2024 saw record margins, $329M net profit, and strong cash flow, led by poultry and pork.JBS
Q2 2024 - Record revenue, margin expansion, and lower leverage highlight robust 2024 performance.JBS
Q4 2024